Test a non-invasive tool to screen for fat-related liver disease
Part of Digestive system, Hormones & metabolism clinical trials.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 80 years old
- Be able and willing to sign informed consent and follow study instructions
- For Part B: you must already have a known MASLD history shown in medical records or scans (like FibroScan or liver ultrasound)
- Do not have alcoholic liver disease or cirrhosis from another cause
- Avoid heavy alcohol use (more than 30 units per week), and do not have an implanted cardiac device
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new ultrasound device that uses sound waves to measure fat in the liver without needles or surgery. It is for people with a type of fatty liver disease called MASLD or MASH, who are already getting an MRI to check their liver.
This study tests a new device called LiverScope® that scans your liver to detect fatty liver disease (MASLD). The scan uses special imaging technology and may help doctors diagnose liver disease more quickly and accurately.
This study is testing whether advanced imaging and other non-invasive methods can properly identify people with significant liver scarring due to metabolic liver disease or alcohol-related liver disease. It may help find better ways to track liver health without repeated needle biopsies.
This study looks at whether a simple blood test (FIB-4) can help detect liver scarring in people with obesity. It may help doctors identify liver problems earlier.
This study tests a new blood test to help diagnose fatty liver disease and liver fibrosis. It aims to see how well the test works compared with a liver biopsy. Your participation could help improve diagnosis for others.
This study is testing a new ultrasound method to measure fat in the liver. It is for people who may have a liver condition or have risk factors like diabetes or obesity, as well as healthy volunteers.
Hear when a new Fatty Liver trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.